The recent instability in global distribution have highlighted the value of securing essential medications like Ivermectin. Dependence on overseas manufacturers exposes regions to significant vulnerabilities, including transportation delays, expense fluctuations, and even geopolitical concerns. Moving towards domestic production of Ivermectin offer